Predicting pregnancy complications with high-plex proteomics
A SomaLogic boutique webinar
Predicting pregnancy complications with high-plex proteomics
The interdisciplinary team, comprising 10-15 scientists and clinician-scientists, is dedicated to advancing diagnostics and therapeutics aimed at enhancing maternal and fetal care. Their primary focus lies in the development of interventions for conditions such as ectopic pregnancy and preeclampsia, alongside the creation of diagnostics to prevent stillbirth. In this webinar, Dr. Lucy Bartho delves into the transformative role of SomaLogic’s SomaScan® assay in their biomarker discovery endeavors. She will also elaborate on how this technology has facilitated the development of clinical tools for the early identification of preeclampsia and fetal growth restriction.
Lucy Bartho, PhD
Dr. Lucy Bartho is a postdoctoral fellow from the Translational Obstetrics Group at the University of Melbourne, co-led by Professor Stephen Tong and Professor Tu’uhevaha Kaitu’u-Lino. The team of 10-15 scientists and clinician-scientists is dedicated to developing diagnostics and therapeutics aimed at enhancing the care of pregnant women and their fetuses. The research arising from the team focuses on identifying novel biomarkers for predicting pregnancy complications, developing treatments for ectopic pregnancy and preeclampsia, and elucidating the pathogenesis of these conditions.
Predicting pregnancy complications with high-plex proteomics
A presentation by Lucy Bartho, PhD
More webinars
WebinarFinding the signal: Identifying reproducible biomarkers in high-plex proteomics
In biomarker discovery, the challenge is rarely a lack of data. Rather, it is knowing how to separate meaningful biological signal from technical distraction. This webinar focuses on how to use univariate analysis as a practical and powerful entry point for biomarker discovery in high-plex proteomics studies.
WebinarMore than the sum of its parts: How harmonized proteomic data reveals meaning across disparate clinical cohorts
Proteomics data generated across sites, time points, and workflows can be difficult to compare using standard normalization alone. This webinar shows how harmonization aligns datasets into a shared biological framework and reveals signals across studies and cohorts, highlighted through the GNPC’s analysis of 40,000 patient samples.
WebinarPathways to Digital Health: AI and Omics in Rheumatoid Arthritis
Explore how groundbreaking proteomic research is transforming our understanding of rheumatoid arthritis (RA). In this on-demand webinar, Allan Stensballe, PhD, shares new insights into the molecular landscape of RA-affected synovial tissue, revealing how autoantibodies and protein signatures may hold the key to more precise personalized therapies.